Logotype for Edible Garden AG Inc

Edible Garden (EDBL) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Edible Garden AG Inc

Q4 2025 earnings summary

10 Apr, 2026

Executive summary

  • Expanded into higher-margin RTD and shelf-stable CPG categories, leveraging existing infrastructure and national retail distribution, with distribution reaching nearly 6,000 retail locations and major e-commerce platforms.

  • Achieved significant growth in cut herbs, vitamin and supplement portfolios, and condiment platforms, supported by new customer wins, expanded e-commerce, and international presence.

  • Strategic investments in onboarding new retail customers, expanding product lines, and RTD manufacturing at the Midwest facility are expected to drive future scalability and margin improvement.

Financial highlights

  • Q4 2025 revenue was $4.1 million, up from $3.9 million in Q4 2024; full-year 2025 revenue was $12.8 million, down from $13.9 million in 2024 due to strategic exit from low-margin lines.

  • Q4 cost of goods sold rose to $5.3 million from $3.8 million, reflecting investments in new customer onboarding.

  • Q4 gross profit was a loss of $1.2 million, with a gross margin of -29%, due to front-loaded costs for securing 2026 shelf space and higher input costs; full-year gross profit was a loss of $0.2 million, with a gross margin of -1.6%.

  • SG&A expenses for the year were $15.6 million, up from $11.6 million, driven by acquisitions, personnel, and capital markets activity.

  • Net loss attributable to common stockholders was $12.6 million for Q4 and $33.9 million for the year.

Outlook and guidance

  • Focus remains on scaling higher-margin RTD and shelf-stable categories, leveraging retail relationships and infrastructure for sustainable long-term growth.

  • Gross margin recovery is a top priority for 2026 as new programs mature, volumes increase, and fixed costs are absorbed.

  • CEA business expected to return to high-single digit growth, with nutraceuticals growing at double-digit rates and RTD margins projected in the 20%-30% range.

  • Midwest RTD facility expected to be operational by late 2027, with significant capacity and retailer demand.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more